Fixing mitophagy in Parkinson's disease

Genentech Inc. has identified ubiquitin specific peptidase 30 as a potentially disease-modifying target involved in the clearance of damaged mitochondria in Parkinson's disease.1 The Roche unit now needs to determine whether the deubiquitinase is indeed druggable.

Mitophagy is a form of autophagy that involves ridding cells of damaged mitochondria and is one of the key pathways for maintaining mitochondrial quality control.2,3 Defects in the process can result in the accumulation of damaged mitochondria within cells, leading to increased oxidative stress and cellular dysfunction.

Genetic studies have identified loss-of-function mutations in two regulators of mitophagy that are associated with PD.4,5 One regulator is PTEN induced putative kinase 1 (PINK1),

Read the full 1069 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE